EP Biocomposites Limited (BOM:543595)
125.45
+2.45 (1.99%)
At close: Apr 23, 2025
EP Biocomposites Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Operating Revenue | 114.46 | 114.39 | 71.31 | 80.6 | 29.48 | 34.09 |
Other Revenue | - | - | - | - | - | 0.01 |
Revenue | 114.46 | 114.39 | 71.31 | 80.6 | 29.48 | 34.1 |
Revenue Growth (YoY) | 41.70% | 60.42% | -11.52% | 173.39% | -13.54% | - |
Cost of Revenue | 67.85 | 70.09 | 41.22 | 49.76 | 18.18 | 28.76 |
Gross Profit | 46.61 | 44.31 | 30.09 | 30.84 | 11.3 | 5.33 |
Selling, General & Admin | 24.62 | 24.26 | 15.95 | 12.96 | 4.72 | 0.5 |
Other Operating Expenses | 3.87 | 3.72 | 3.42 | 4.05 | 1.98 | 2.24 |
Operating Expenses | 29.58 | 28.98 | 20.36 | 17.67 | 6.71 | 2.74 |
Operating Income | 17.03 | 15.33 | 9.72 | 13.17 | 4.6 | 2.59 |
Interest Expense | -1.92 | -0.35 | -2.03 | -1.56 | - | - |
Interest & Investment Income | 0.73 | 0.73 | 0.45 | 0.06 | 0.03 | - |
Other Non Operating Income (Expenses) | -0 | -0 | -0 | - | 0.02 | - |
Pretax Income | 15.84 | 15.7 | 8.14 | 11.66 | 4.64 | 2.59 |
Income Tax Expense | 4.5 | 4.21 | 2.38 | 3.57 | 1.06 | 0.7 |
Net Income | 11.34 | 11.5 | 5.76 | 8.09 | 3.58 | 1.9 |
Net Income to Common | 11.34 | 11.5 | 5.76 | 8.09 | 3.58 | 1.9 |
Net Income Growth | 116.43% | 99.55% | -28.82% | 126.09% | 88.82% | - |
Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 0 | - |
Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 0 | - |
Shares Change (YoY) | 0.55% | 15.13% | 71.17% | 127.55% | - | - |
EPS (Basic) | 6.72 | 6.84 | 3.94 | 9.49 | 9.55 | - |
EPS (Diluted) | 6.72 | 6.84 | 3.94 | 9.48 | 9.55 | - |
EPS Growth | 115.50% | 73.52% | -58.44% | -0.70% | - | - |
Free Cash Flow | -27.78 | -14.8 | -8.17 | -47.55 | 0.32 | 6.97 |
Free Cash Flow Per Share | -16.47 | -8.80 | -5.59 | -55.72 | 0.85 | - |
Gross Margin | 40.72% | 38.73% | 42.19% | 38.26% | 38.34% | 15.64% |
Operating Margin | 14.88% | 13.40% | 13.63% | 16.34% | 15.60% | 7.60% |
Profit Margin | 9.91% | 10.05% | 8.08% | 10.04% | 12.14% | 5.56% |
Free Cash Flow Margin | -24.27% | -12.94% | -11.45% | -58.99% | 1.08% | 20.45% |
EBITDA | 18.12 | 16.33 | 10.72 | 13.83 | 4.6 | - |
EBITDA Margin | 15.83% | 14.28% | 15.03% | 17.16% | 15.61% | - |
D&A For EBITDA | 1.09 | 1.01 | 1 | 0.66 | 0 | - |
EBIT | 17.03 | 15.33 | 9.72 | 13.17 | 4.6 | 2.59 |
EBIT Margin | 14.88% | 13.40% | 13.63% | 16.34% | 15.60% | 7.60% |
Effective Tax Rate | 28.41% | 26.79% | 29.22% | 30.58% | 22.88% | 26.85% |
Revenue as Reported | 117.03 | 117.38 | 72.97 | 80.76 | 29.52 | 34.1 |
Advertising Expenses | - | 0.29 | 0.19 | 0.11 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.